Reducing CD73 expression by IL1β-Programmed Th17 cells improves immunotherapeutic control of tumors.

Chatterjee S, Thyagarajan K, Kesarwani P, et al. "Reducing CD73 expression by IL1β-Programmed Th17 cells improves immunotherapeutic control of tumors." Cancer Res.. 2014;74(21):6048-59.